US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

210.78

-21.2100-9.14%

Post-market: 212.771.99+0.94%19:59 EDT

Volume:426.63K

Turnover:92.65M

Market Cap:563.73M

PE:- -

High:229.00

Open:229.00

Low:210.16

Close:231.99

52wk High:341.93

52wk Low:102.35

Shares:2.67M

Float Shares:2.67M

Volume Ratio:0.68

T/O Rate:15.95%

Dividend:0.90

Dividend Rate:0.43%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product

Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell

MT Newswires Live

EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions

Perspective Therapeutics Wins FDA Fast Track for PSV359

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)

Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

Health Care Roundup: Market Talk

Daiichi-Linked Investors Exit Substantial Holding in Ramsay Health Care

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Demant (OtherWILLF)

Allist Pharmaceuticals Hits 20cm Limit Down, Market Cap Plummets Over 10 Billion Yuan in One Day; Zhongou Healthcare Mixed A Faces Nearly 20 Million Yuan Paper Loss

Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal

Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review

Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate

MT Newswires Live

Top Executive Makes Major Move With Alignment Healthcare Stock

IHH Healthcare Looks Attractive on Recent Share Price Weakness

Imricor Medical Systems Says FDA Completes Review of PMA Module Three

MT Newswires Live

Imricor Clears Major FDA Hurdle on MR-Guided Ablation Platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":210.78,"timestamp":1791921600000,"preClose":231.99,"halted":0,"volume":426634,"hourTrading":{"tag":"盘后","latestPrice":212.77,"preClose":210.78,"latestTime":"19:59 EDT","volume":16334,"amount":3477575.9866,"timestamp":1791935972818,"change":1.99,"changeRate":0.009441,"amplitude":0.012904},"delay":0,"changeRate":-0.09142635458424936,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"Not Yet Opened","change":-21.21,"latestTime":"10-13 16:00:00 EDT","open":229,"high":229,"low":210.1596,"amount":92647400.00698,"amplitude":0.081212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":231.99,"sharesOutstanding":3074486,"nav":231.877,"aum":620152459.74,"dividendRate":0.004293,"bidAskSpread":0.003009,"preHourTrading":{"tag":"盘前","latestPrice":228,"preClose":231.99,"latestTime":"09:29 EDT","volume":2274,"amount":529315.02324,"timestamp":1791898190029,"change":-3.99,"changeRate":-0.017199,"amplitude":0.03664},"postHourTrading":{"tag":"盘后","latestPrice":212.77,"preClose":210.78,"latestTime":"19:59 EDT","volume":16334,"amount":3477575.9866,"timestamp":1791935972818,"change":1.99,"changeRate":0.009441,"amplitude":0.012904},"volumeRatio":0.679063,"impliedVol":0.9697,"impliedVolPercentile":0.7131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.679063,"shares":2674486,"dividePrice":0.9048,"high":229,"amplitude":0.081212,"preClose":231.99,"low":210.1596,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":210.78,"eps":0,"divideRate":0.004293,"volume":426634,"delay":0,"ttmEps":0,"open":229,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":230.95,"twentyDayClose":250.4,"sixtyDayClose":249.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673007412","title":"Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673007412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673007412?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass.--(BUSINESS WIRE)--October 08, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per sh","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4203","BK4581","BK4585","LABU","DHC","BK4588","XBI","XLV","HAUS","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114859472","title":"Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1114859472","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114859472?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:58","pubTimestamp":1791457108,"startTime":"0","endTime":"0","summary":"Xiamen Kingdomway Group Company (002626.SZ) has announced that its wholly-owned subsidiary, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (\"Kingdomway Pharmaceutical\"), recently received a no...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","159100","BK4585","BK0226","BK0197","BK0191","BK0077","LABU","002626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673407600","title":"Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673407600","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673407600?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:53","pubTimestamp":1791456799,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics  said Thursday that the US Food and Drug Administration, or FDA, granted fast track designation for the development of PSV359, an experimental cancer treatment for adults with advanced tumors that cannot be removed through surgery or have spread to other parts of the body.The investigational therapy is being studied in an ongoing Phase 1/2a trial in patients with advanced fibroblast activation protein-positive solid tumors, the company said.The company said early human imaging data showed strong tumor uptake and rapid kidney clearance for PSV359.The FDA's fast track program is aimed at accelerating the development and review of therapies for serious conditions with unmet medical needs, the company added.Shares rose around 4.9% in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","CATX","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079644","title":"EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079644","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079644?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:51","pubTimestamp":1791456679,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has provided an announcement. Malaysia’s Employees Provident Fund Board has increased its direct stake in IHH Healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","BK4585","BK4137","XLV","HCSG","LU0029874061.USD","BK4581","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079980","title":"Perspective Therapeutics Wins FDA Fast Track for PSV359","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079980?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:48","pubTimestamp":1791456486,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics ( ($CATX) ) has issued an update. On October 8, 2026, Perspective Therapeutics announced that the U.S. Food and Drug Admin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","CATX","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673076180","title":"Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673076180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673076180?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:30","pubTimestamp":1791455457,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mirum Pharmaceuticals (MIRM), Connect Biopharma Hold...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4588","BK4007","HELP","BK4137","BK4139","BK4581","LABU","LU0128526141.USD","CNTB","XBI","MIRM","BK4585","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125924715","title":"Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1125924715","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125924715?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:38","pubTimestamp":1791452288,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare (Group) Co., Ltd. (ASX: 600079.SH) announced that its controlling subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (Yichang Humanwell), has received approval from the U.S....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0012","600079","BK0239","BK4585","BK0028","BK4588","LABU","BK0185","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207450","title":"Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207450?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:10","pubTimestamp":1791450618,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Rocket Pharmaceuticals (RCKT) and Chemed (CHE). Ro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1721427968.SGD","BK4585","CHE","BK4581","LU0128526141.USD","LU1620156213.USD","BK4137","LU1596574779.USD","XBI","LU1165135440.EUR","RCKT","BK4196","BK4588","LU1543694498.USD","IE00B64QTZ34.USD","LU2413665964.HKD","XLV","LU1620156130.USD","LABU","HCSG","IE00BLDYK493.USD","LU2413666004.HKD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776027","title":"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776027?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:40","pubTimestamp":1791448815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ) and NeoGenomics (NEO). Johnson & Johnson ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-neogenomics-neo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-neogenomics-neo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1718418525.SGD","LU1674673691.USD","LU1929549753.HKD","LU2505996681.GBP","JDOC","XBI","LU1551013342.USD","LU1261432733.SGD","HCSG","IXJ","IHE","IE000M9KFDE8.USD","LU2592432038.USD","LABU","IE0002270589.USD","VHT","FHLC","XLV","NEO","FBT","LU1066053197.SGD","MEDX","LU0545039389.USD","IE00B19Z3581.USD","IE00B3PB1722.GBP","LU1057294990.SGD","BMED","PJP","FTXH","IE00BFTCPJ56.SGD","LU0640476718.USD","BK4592","LU0234570918.USD","LU1145028129.USD","IE00B4R5TH58.HKD","LU0795875169.SGD","LU2756315664.SGD","GDOC","TRUH","LU1228905037.USD","LU0345769631.USD","LU1059921491.USD","LU0432979614.USD","RXL","LU0098860793.USD","LU0426412945.USD","JNJ","IYH","LU1032466523.USD","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673225620","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2673225620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673225620?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:20","pubTimestamp":1791447600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0707 GMT - Fresenius Medical Care's surprise CEO change will be ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XLV","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021086","title":"Daiichi-Linked Investors Exit Substantial Holding in Ramsay Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021086","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021086?lang=en_us&edition=fundamental","pubTime":"2026-10-08 15:37","pubTimestamp":1791445038,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has shared an update. Ramsay Health Care has disclosed that TAL Daiichi Life Australia and its related Daiichi Lif...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/daiichi-linked-investors-exit-substantial-holding-in-ramsay-health-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/daiichi-linked-investors-exit-substantial-holding-in-ramsay-health-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","IE00B0JY6N72.USD","XBI","LABU","BK4211","BK4510","BK4204","BK4531","XLV","BK4581","BK4585","BK4548","LU1880383366.USD","BK4506","BK4588","BK4503","ISBC","BK4535","TAL","LU1880383440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673260900","title":"Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Demant (OtherWILLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673260900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673260900?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:50","pubTimestamp":1791442209,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CSL (CMXHF) and Demant (WILLF). CSL (CMXHF) In a r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-csl-othercmxhf-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-csl-othercmxhf-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","XBI","BK4139","BK4585","WILLF","BK4588","HCSG","BK4137","BK4581","XLV","BK4082","LU0029874061.USD","CMXHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138310246","title":"Allist Pharmaceuticals Hits 20cm Limit Down, Market Cap Plummets Over 10 Billion Yuan in One Day; Zhongou Healthcare Mixed A Faces Nearly 20 Million Yuan Paper Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1138310246","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138310246?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:00","pubTimestamp":1791439238,"startTime":"0","endTime":"0","summary":"On the first trading day after the 2026 National Day holiday, Shanghai Allist Pharmaceuticals Co.,Ltd. (688578.SH) hit the daily limit down on a one-word board due to the global Phase III clinical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK0239","159760","688578","BK4585","IXJ","XBI","LABU","VHT","XLV","BK4550","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673023380","title":"Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal","url":"https://stock-news.laohu8.com/highlight/detail?id=2673023380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673023380?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:34","pubTimestamp":1791437660,"startTime":"0","endTime":"0","summary":"Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has shared an announcement. Newron Pharmaceuticals said the U.S. FDA has issued a clinical hold on U.S. t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-evenamide-phase-3-as-fda-halts-u-s-arm-over-safety-signal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-evenamide-phase-3-as-fda-halts-u-s-arm-over-safety-signal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SYNB","BK4585","IBB","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673023384","title":"Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review","url":"https://stock-news.laohu8.com/highlight/detail?id=2673023384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673023384?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:32","pubTimestamp":1791437568,"startTime":"0","endTime":"0","summary":"An announcement from Newron Pharmaceuticals SpA ( ($CH:NWRN) ) is now available. Newron Pharmaceuticals has received a formal notification from the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","BK4588","IBBQ","PTH","IBB","LABU","BBC","SYNB","BIS","BK4585","PSCH","PILL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044724","title":"Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044724","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044724?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:24","pubTimestamp":1791426258,"startTime":"0","endTime":"0","summary":"Noxopharm   said the US Food and Drug Administration has provided constructive feedback that was supportive of its planned approach for a phase II clinical trial for SOF-SKN, its autoimmune disease drug candidate, according to a Thursday Australian bourse filing.The company said the feedback provides increased regulatory clarity, and helps de-risk the drug candidate's development pathway, while it will incorporate the feedback into preparations for a future investigational new drug  submission that has the potential to increase SOF-SKN's commercial attractiveness.The phase II trial is targeted for the first half of calendar 2028, subject to regulatory, clinical and manufacturing requirements, it said.The company said an orphan drug designation opportunity exists for SOF-SKN, given there are no current targeted therapies.The company's shares fell nearly 2% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","NOX.AU","BK7067","BK7501","BK4585","IND.AU","BK7095","BK4588","IND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044473","title":"Top Executive Makes Major Move With Alignment Healthcare Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044473","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044473?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:02","pubTimestamp":1791424972,"startTime":"0","endTime":"0","summary":"New insider activity at Alignment Healthcare ( ($ALHC) ) has taken place on October 7, 2026. Alignment Healthcare’s Chief Medical Officer, Hyong Ki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alignment-healthcare-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alignment-healthcare-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALHC","BK4585","XLV","BK4588","BK4154","BK4581","LABU","XBI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049067","title":"IHH Healthcare Looks Attractive on Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673049067?lang=en_us&edition=fundamental","pubTime":"2026-10-08 09:08","pubTimestamp":1791421680,"startTime":"0","endTime":"0","summary":"0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","XLV","LABU","BK4581","LU0029874061.USD","BK4588","BK4585","HCSG","XBI","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673046364","title":"Imricor Medical Systems Says FDA Completes Review of PMA Module Three","url":"https://stock-news.laohu8.com/highlight/detail?id=2673046364","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673046364?lang=en_us&edition=fundamental","pubTime":"2026-10-08 07:41","pubTimestamp":1791416498,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the US Food and Drug Administration has completed its review of module three of the company's premarket approval  submission, which covers non-clinical bench testing for its Vision-MR ablation catheter 2.0, RF-5000 system and irrigation tubing set, according to a Thursday Australian bourse filing.No deficiencies were identified in the catheter or tubing set, while one deficiency was found in the RF-5000 system's third-party software operating system, which the company has already upgraded to a long-term supported version, per the filing.The company is preparing its response to the FDA, with module three expected to close upon acceptance and module four targeted for submission in November, thereby completing all PMA submissions, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4129","PMA","BK7007","LABU","IMR.AU","BK4585","BK4588","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673045533","title":"Imricor Clears Major FDA Hurdle on MR-Guided Ablation Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673045533","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673045533?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:29","pubTimestamp":1791412149,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ). Imricor Medical Systems, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/imricor-clears-major-fda-hurdle-on-mr-guided-ablation-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/imricor-clears-major-fda-hurdle-on-mr-guided-ablation-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":8,"totalSize":398,"code":"91000000","status":"200"}]}}